Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Esjay Pharma
Sriperumbudur, Tamil Nadu, Indiaesjaypharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Esjay Pharma holds regulatory approvals in major markets, with key small molecule drugs such as ergocalciferol, calcitriol, bromocriptine mesylate, and methenamine hippurate approved and commercially available for indications including endocrine, renal, neurologic and infectious diseases.[3]
- Therapeutic areas
- NephrologyInfectious DiseasesEndocrinologyDermatology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Esjay Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Esjay Pharma.